首页 › 基金 › SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC › CSTL
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 对 CSTL 的持仓历史
CASTLE BIOSCIENCES INC · 医疗保健
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 CSTL(CASTLE BIOSCIENCES INC)635,000 股,市值约 US$22.6M,约占其申报组合的 0.67%,在其申报持仓中市值排名第 44 位。 SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 最近 5 个申报季度中有 5 个季度披露了 CSTL 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 对 CSTL 的持仓演变
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 于 Q3 2025 首次披露 CSTL 持仓:400,000 股(约 US$9.1M)。 该持仓在 Q4 2025 达到峰值 1,058,725 股,市值约 US$41.2M。 在 5 次申报中,SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 1 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 635,000 股、市值约 US$22.6M,环比减持 -189,872 股。。 持仓曾出现大幅变动:Q4 2025 增持约 165% (随后一个季度股价下跌 37%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 400.00K | $9.11M | 新进 |
| Q4 2025 | 1.06M | $41.18M | 增持 |
| Q1 2026 | 940.68K | $23.09M | 减持 |
| Q2 2026 | 824.87K | $19.67M | 减持 |
| Q3 2026 | 635.00K | $22.56M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CSTL 与 13F 数据
CSTL(CASTLE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 CSTL,申报仓位最大的包括:RTW INVESTMENTS, LP (US$98.7M), Parkman Healthcare Partners LLC (US$13.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CSTL 的基金
- RTW INVESTMENTS, LP 2.78M 股 · $98.71M · Q3 2026
- Parkman Healthcare Partners LLC 367.91K 股 · $13.07M · Q3 2026
更多关于 SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
常见问题
How long has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC held CSTL?
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has disclosed CSTL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's current position in CSTL?
As of Q3 2026, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds 635.00K shares of CSTL (CASTLE BIOSCIENCES INC), valued at $22.56M, representing 0.67% of its reported portfolio and ranking #44.
Has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC been buying or selling CSTL?
In the latest 13F filing (Q3 2026), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reduced its position in CSTL. The position peaked in Q4 2025 at 1.06M shares.
Which other funds hold CSTL?
Other major institutional holders of CSTL include RTW INVESTMENTS, LP, Parkman Healthcare Partners LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.